Delivery Order SPE2DR25D3011-SPE2DR26FW37D
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100 count) valued at $1,144.66, with an ultimate completion date of November 17, 2025. This non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical procurement needs. The award was issued on November 14, 2025, with performance conducted at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) valued at $4,134.36 under a firm fixed price contract type. This delivery order, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $1,212.48. Issued on September 16, 2025, this firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a contract value of $1,246.45. This non-set-aside, competitively awarded delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, under firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $2,283.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,702.96 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Methylphenidate ER 18 mg tablets (100-count units) under a firm fixed-price contract valued at $1,831.30. The award, made on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $1,024.91 under a firm fixed-price contract type. The award was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $4,382.80. This competitively awarded, firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was...
- SPE2DR25D3011Indefinite Delivery Contract
- SPE2DR25D3011-SPE2DR26FW37DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count containers) under a firm fixed-price contract with a ceiling value of $1,252.88. The award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This delivery order for Methylphenidate ER reflects the company's role as a critical pharmaceutical vendor for federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/30/25 |